By Melissa Lipman ( January 4, 2010, 3:28 PM EST) -- A federal judge has ruled that Teva Pharmaceuticals USA Inc. and several other generic-drug makers have induced infringement of an Eli Lilly & Co. patent for attention deficit hyperactivity disorder treatment Strattera, but left unanswered questions as to whether the patent is valid and enforceable....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.